Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
Iman Razeghian‐Jahromi, Mohammad Javad Zibaeenezhad, Zhibing Lu, Zahra Elyaspour, Mahboobeh Razmkhah, Vincenzo Lionetti
Topics & Concepts
MedicineHeart failureInternal medicineDiseaseIntensive care medicineCardiologyAngiotensin-converting enzyme 2PandemicCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19